FDA Inspection
Banco De Sangre Humacao, Inc.Banco De Sangre Humacao, Inc. – FDA Inspection, Jul 3, 2013
Record Details
This FDA Inspection record concerns Banco De Sangre Humacao, Inc., with an inspection on July 3, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 3, 2013
- Product Type
- Biologics
View Company Profile
ID · 1d96afdd-1a3a-46e4-8263-4f142ae2f244
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 839826
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Banco De Sangre Humacao, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2025 | Not classified | San Juan District Office | |
| July 21, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 1, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 30, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 7, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Banco De Sangre Humacao, Inc.
- FDA Inspection 1274521 - 2025-06-23
- FDA Inspection 1175401 - 2022-07-21
- FDA Inspection 1053320 - 2018-05-01
- FDA Inspection 719126 - 2011-03-30
- FDA Inspection 603590 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.